ArticleOncotarget2017

Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.

Xuesai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.